PSMC4 promotes low-grade glioma progression and predicts poor prognosis
PSMC4 overexpression promotes LGG progression and may be an independent marker of poor prognosis. Targeting PSMC4 can reduce tumor growth and metastasis, providing a promising strategy for LGG treatment. Further research on its regulatory mechanisms and clinical implications is warranted.
Authors
- DU Zhongliang
- Hui Zhao (ORCID: https://orcid.org/0000-0002-0872-8528)
- Bie Huijie
- Zhao Yanhong
- Qian Liquan
- Wang Ming
- Wang Liping
- Cui Dongjuan
- Si Yunhui
Institutions
- Shangqiu Institute of Technology (CN)
- Shangqiu First People's Hospital (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1186/s40001-026-03914-y
- Primary Topic
- Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00